Medical articles on Wikipedia receive about 150 million page views per month, and nearly 50% of practicing physicians use Wikipedia as an information source for providing medical care. And while Wikipedia itself has disclaimers that information included on its site may be inaccurate,
Medical articles on Wikipedia receive about 150 million page views per month, and nearly 50% of practicing physicians use Wikipedia as an information source for providing medical care. And while Wikipedia itself has disclaimers that information included on its site may be inaccurate, that doesn’t stop consumers and medical professionals alike from using it as a health source that they consider credible. What should we do? Stop sticking our head in the sand and take accountability to fix this very concerning public health issue.
I recently spoke with a colleague whose doctor’s medical assistant provided her with incorrect information and referenced Wikipedia as the source. Thankfully, she knew enough to go online herself (not to Wikipedia!) and learned the information was wrong. But, that’s not the case for many consumers. They trust their medical professionals without question, and believe that everything they read online is fact, especially from such a popular site as Wikipedia – never realizing that the information might be inaccurate and sometimes downright dangerous.
Those in the healthcare industry, especially drug manufacturers and the FDA, have a public health responsibility to play a role in helping to fix the inaccuracies and incomplete information on Wikipedia. Sure, there are some challenges – like the perception that the drug manufacturers have a conflict of interest or that getting anywhere near user-generated content will result in a visit from the FDA, but we should work toward common sense solutions.
Drug manufacturers, though they must be very careful in how they edit content on Wikipedia to avoid having a conflict of interest, should document and notify Wikipedia when content is inaccurate or incomplete. In fact, each Wikipedia article has a discussion area where a company representative could post the suggested changes or additions, leaving the broader community to determine if it should or shouldn’t be included. No, this isn’t a perfect solution, but at least the manufacturers would be doing their part to try to fix the inaccuracies. And the FDA should either establish clear guidelines around user-generated content, or let manufacturers do what’s right in trying to correct inaccurate information, without fear of repercussions.
Wikipedia has a role to play as well – it needs to embrace drug manufacturers and assume they have the right intent in ensuring accurate information is available to the public. Some might argue that drug manufacturers in the past have been caught trying to game the system by removing damaging information about their products. But the beauty of Wikipedia is that the community will find and fix those self-serving changes. The sins of a few shouldn’t punish everyone else’s access to accurate and complete health information.
Let’s step up and make some real and meaningful changes soon. The public’s health depends on it.
Beth Bengtson is principal at Hale Advisors, a healthcare marketing and communications company. You can email her at beth@haleadvisors.com or follower her on Twitter at @b2engt.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.